Breaking News Instant updates and real-time market news.

AVEO

Aveo Pharmaceuticals

$0.92

-0.0299 (-3.15%)

16:08
04/23/19
04/23
16:08
04/23/19
16:08

Aveo Pharmaceuticals announces $2M payment for commercialization of Fotivda

AVEO Oncology announced the triggering of a $2M milestone payment to AVEO from EUSA Pharma. The milestone payment relates to the reimbursement approval and commercial launch in Spain of FOTIVDA as a first line treatment of adult patients with advanced renal cell carcinoma. Commercial launch in Spain is the third of five EU5 country launches to trigger a $2 million payment under the terms of AVEO's license agreement with EUSA Pharma. In the European Union, Norway and Iceland, tivozanib is indicated for the first line treatment of adult patients with RCC and for adult patients who are vascular endothelial growth factor receptor and mTOR pathway inhibitor-naive following disease progression after one prior treatment with cytokine therapy for RCC.

AVEO Aveo Pharmaceuticals
$0.92

-0.0299 (-3.15%)

02/19/19
PIPR
02/19/19
NO CHANGE
Target $3
PIPR
Overweight
Aveo Pharmaceuticals should be bought on any weakness, says Piper Jaffray
Aveo Pharmaceuticals' full Phase III Tivo-3 data for tivozanib in an oral presentation on Saturday "showed clear advantage" for progression-free survival, overall response rate and safety, but the "immature" overall survival data show a hazard ratio of 1.12, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. The analyst believes that with more patients still on tivozanib, the hazard ratio could slip below 1.0 and meet the FDA filing requirement. He recommends buying shares of Aveo on weakness and keeps an Overweight rating on the name with a $3 price target.
03/15/19
03/15/19
NO CHANGE

Baird reiterates Outperform rating on Aveo after Q4 earnings
Baird analyst Madhu Kumar reiterated an Outperform rating and $2 price target on Aveo Pharmaceuticals after the company reported its Q4 earnings report. The analyst said in a research note partially titled "Clinical Basis for TIVO-3 OS Optimism" that he continues to have relative optimism to the Street for Fotivda, and added that a Q4 of 2019 update on TIVO-3 OS was a key potential positive catalyst for the stock.
03/28/19
NATL
03/28/19
INITIATION
NATL
Sell
Aveo Pharma initiated with a Sell, $0 price target at National Securities
National Securities initiated Aveo Pharmaceuticals with a Sell and $0 price target saying recent share appreciation is "totally unwarranted." The firm's analyst expects interim and final Phase 3 overall survival data updates to fail to support a Tivozanib NDA filing.
04/04/19
PIPR
04/04/19
NO CHANGE
Target $3
PIPR
Overweight
Piper maintains Overweight rating, $3 target on Aveo after stock sale
Piper Jaffray analyst Edward Tenthoff maintains his Overweight rating and $3 price target on Aveo Pharmaceuticals after the company "opportunistically" raised $25M by issuing 21.7M shares at $1.15 per share and 21.7M in warrants with a $1.25 strike price. The analyst, who estimates that Aveo now holds pro forma cash of about $57M, said the primary driver for the stock remains the OS analysis for TIVO-3 that is scheduled to be reported in Q4. If the hazard ratio does not drop to less than 1.0 for tivozanib, Tenthoff does not believe the FDA will accept a new NDA filing, he noted.

TODAY'S FREE FLY STORIES

MBIO

Mustang Bio

$4.65

0.61 (15.10%)

08:05
08/22/19
08/22
08:05
08/22/19
08:05
Hot Stocks
Mustang Bio granted RMAT designation for MB-107 for XSCID »

Mustang Bio and St. Jude…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

LOW

Lowe's

$108.00

9.96 (10.16%)

08:04
08/22/19
08/22
08:04
08/22/19
08:04
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 20

    Nov

TRHC

Tabula Rasa HealthCare

$64.93

1.38 (2.17%)

08:03
08/22/19
08/22
08:03
08/22/19
08:03
Hot Stocks
Tabula Rasa HealthCare announces partnership with Bainbridge Health Partners »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

MYL

Mylan

$19.07

-0.02 (-0.10%)

, NVO

Novo Nordisk

$51.82

0.54 (1.05%)

08:02
08/22/19
08/22
08:02
08/22/19
08:02
Periodicals
Novo Nordisk sues Mylan for alleged patent infringement, Reuters reports »

Mylan (MYL) has been sued…

MYL

Mylan

$19.07

-0.02 (-0.10%)

NVO

Novo Nordisk

$51.82

0.54 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 25

    Sep

TREX

Trex Company

$85.68

-0.085 (-0.10%)

08:01
08/22/19
08/22
08:01
08/22/19
08:01
Initiation
Trex Company initiated  »

Trex Company initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

AFL

Aflac

$48.98

-2.88 (-5.55%)

08:00
08/22/19
08/22
08:00
08/22/19
08:00
Hot Stocks
Aflac says not anticipating any disruption in long-term JPH Alliance plans »

Aflac said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$30.14

4.165 (16.04%)

08:00
08/22/19
08/22
08:00
08/22/19
08:00
Options
Pinduoduo call buyer realizes 21% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
08/22/19
08/22
08:00
08/22/19
08:00
General news
Treasury Market Outlook: yields are higher »

Treasury Market Outlook:…

AFL

Aflac

$48.98

-2.88 (-5.55%)

07:59
08/22/19
08/22
07:59
08/22/19
07:59
Hot Stocks
Aflac says 'rigorous, voluntary review' of postal channel sales began in July »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:53
08/22/19
08/22
07:53
08/22/19
07:53
Conference/Events
Citigroup to hold a forum »

Citi-REITAS-SGX C-Suite…

JEC

Jacobs Engineering

$86.06

2.45 (2.93%)

07:51
08/22/19
08/22
07:51
08/22/19
07:51
Hot Stocks
Jacobs Engineering appointed as smart meter specialist in Singapore »

Jacobs has been appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSGN

MSG Networks

$14.78

-2.07 (-12.28%)

07:51
08/22/19
08/22
07:51
08/22/19
07:51
Recommendations
MSG Networks analyst commentary  »

MSG Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$71.77

0.44 (0.62%)

07:50
08/22/19
08/22
07:50
08/22/19
07:50
Upgrade
Cerner rating change  »

Cerner upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

ADMA

ADMA Biologics

$4.05

-0.01 (-0.25%)

07:50
08/22/19
08/22
07:50
08/22/19
07:50
Hot Stocks
ADMA Biologics announces commercial relaunch of BIVIGAM »

ADMA Biologics announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

FLWS

1-800-Flowers.com

$19.36

0.74 (3.97%)

07:48
08/22/19
08/22
07:48
08/22/19
07:48
Earnings
1-800-Flowers.com sees FY20 EPS up 8%-10% »

Sees FY20 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

FLWS

1-800-Flowers.com

$19.36

0.74 (3.97%)

07:48
08/22/19
08/22
07:48
08/22/19
07:48
Earnings
1-800-Flowers.com reports Q4 adj. EPS (12c), consensus (14c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

SQM

SQM

$25.40

-0.86 (-3.27%)

07:45
08/22/19
08/22
07:45
08/22/19
07:45
Downgrade
SQM rating change  »

SQM downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

SEDG

SolarEdge

$87.87

3.16 (3.73%)

07:44
08/22/19
08/22
07:44
08/22/19
07:44
Downgrade
SolarEdge rating change  »

SolarEdge downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$84.51

2.27 (2.76%)

07:43
08/22/19
08/22
07:43
08/22/19
07:43
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:42
08/22/19
08/22
07:42
08/22/19
07:42
Hot Stocks
Dick's Sporting reports Q2 eCommerce sales up 21% »

eCommerce penetration for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

FLR

Fluor

$17.35

0.3 (1.76%)

07:41
08/22/19
08/22
07:41
08/22/19
07:41
Upgrade
Fluor rating change  »

Fluor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:40
08/22/19
08/22
07:40
08/22/19
07:40
Hot Stocks
Dick's Sporting up 10% after Q2 results beat estimates, FY19 profit view raised »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PDD

Pinduoduo

$30.14

4.165 (16.04%)

07:39
08/22/19
08/22
07:39
08/22/19
07:39
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:38
08/22/19
08/22
07:38
08/22/19
07:38
Earnings
Dick's Sporting says FY19 EPS guidance includes expected tariff impacts »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TGT

Target

$103.11

17.54 (20.50%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Recommendations
Target analyst commentary  »

Target valuation remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.